The auto-inhibitory role of the EPAC hinge helix as mapped by NMR.
The cyclic-AMP binding domain (CBD) is the central regulatory unit of exchange proteins activated by cAMP (EPAC). The CBD maintains EPAC in a state of auto-inhibition in the absence of the allosteric effector, cAMP. When cAMP binds to the CBD such auto-inhibition is released, leading to EPAC activat...
Main Authors: | Rajeevan Selvaratnam, Mohammad T Mazhab-Jafari, Rahul Das, Giuseppe Melacini |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3504058?pdf=render |
Similar Items
-
Recent Advances in EPAC-Targeted Therapies: A Biophysical Perspective
by: Alveena Ahmed, et al.
Published: (2019-11-01) -
The Role of Epac in Cancer Progression
by: Nadine Wehbe, et al.
Published: (2020-09-01) -
Structure-guided design of selective Epac1 and Epac2 agonists.
by: Frank Schwede, et al.
Published: (2015-01-01) -
cAMP-EPAC-Dependent Regulation of Gephyrin Phosphorylation and GABAAR Trapping at Inhibitory Synapses
by: Fumihiro Niwa, et al.
Published: (2019-12-01) -
The nucleotide addition cycle of RNA polymerase is controlled by two molecular hinges in the Bridge Helix domain
by: Weinzierl Robert OJ
Published: (2010-10-01)